(marketscreener.com) MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their Cardionomic Pulmonary Neuromodulation System Pilot Study. The study will evaluate the safety and performance of the CPNS in patients suffering from Acute Decompensated Heart Failure,...https://www.marketscreener.com/news/latest/Cardionomic-Announces-First-Patients-Enrolled-in-CPNS-Pilot-Study--32979286/?utm_medium=RSS&utm_content=20210415